Fonte: Resumos. Nome do evento: ENDO 06 - Annual Meeting the endocrine society's. Unidade: FM
Assuntos: FATORES DE RISCO, DOENÇAS CARDIOVASCULARES, GLICOSE (CONTROLE), RESUMOS (CONGRESSOS)
ABNT
DAVINI, Elaine et al. Beneficial effects of rosiglitazone and metformin associated with glibenclamide on glucose control and cardiovascular risk factors. 2006, Anais.. Boston: Faculdade de Medicina, Universidade de São Paulo, 2006. . Acesso em: 03 out. 2024.APA
Davini, E., Tostes, G. C. U., Cunha, M. R., Wajchenberg, B. L., Correia, M. R. S., Fukui, R. T., et al. (2006). Beneficial effects of rosiglitazone and metformin associated with glibenclamide on glucose control and cardiovascular risk factors. In Resumos. Boston: Faculdade de Medicina, Universidade de São Paulo.NLM
Davini E, Tostes GCU, Cunha MR, Wajchenberg BL, Correia MRS, Fukui RT, Santos AS, Rocha DM, Ursich MJM, Silva MER. Beneficial effects of rosiglitazone and metformin associated with glibenclamide on glucose control and cardiovascular risk factors. Resumos. 2006 ;[citado 2024 out. 03 ]Vancouver
Davini E, Tostes GCU, Cunha MR, Wajchenberg BL, Correia MRS, Fukui RT, Santos AS, Rocha DM, Ursich MJM, Silva MER. Beneficial effects of rosiglitazone and metformin associated with glibenclamide on glucose control and cardiovascular risk factors. Resumos. 2006 ;[citado 2024 out. 03 ]